UFC fighter Oskar Piechota has been given a 22-month suspension by the U.S. Anti-Doping Agency due to a test collected in the fall. Piechota tested positive for GHRP-2 (growth hormone releasing peptide 2), which is not allowed under the current policy in place.
The suspension began on September 25th last year, per an announcement made by USADA on Wednesday. Piechota was originally set to be suspended for 24 months, although the penalty was slightly deducted due to his ‘Full and Complete Cooperation.”
Piechota last competed in June of 2020, where Marc-Andre Barriault stopped him in the second round of action. The result of the fight was later overturned to a no contest due to a drug test on Barriault.
Prior to the fight, Piechota had taken three consecutive losses in the UFC.